Sun, Feb 1, 2015, 4:16 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • thinkabout1120 thinkabout1120 Jan 29, 2013 4:09 PM Flag

    Batzem, what is your price target this year?

    Unfortunately, for we longs Dacogen loses its “protective” status this May.
    While we will not feel an instant drop in revenues; never the less the market looks forward. Sadly we are not close to any new approved compound. Maybe someone out there knows a better date, but right now it looks at least 18 months out to even get a chance at one of the science projects proving out successfully!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Think,

      Name the generic company? Why would you claim to be long, but think the share price is headed south. The market out there for dacogen is roughly $200M. I don't see a generic entering the picture. Just like vidaza. With the EU aml approval, we could be looking at $90M in revenues this year. But do some DD, show us a real concern. Until and unless you do research, you are as insignificant as loverboy.

      Sentiment: Strong Buy

8.4950.0000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gran Tierra Energy, Inc.
AMEXFri, Jan 30, 2015 4:01 PM EST
Middleby Corp.
NASDAQFri, Jan 30, 2015 4:00 PM EST